Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
29.78
+0.26 (0.88%)
At close: Aug 22, 2025, 4:00 PM
30.13
+0.35 (1.18%)
After-hours: Aug 22, 2025, 7:08 PM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$86.64
Upside
+190.93%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $136 → $128 | Strong Buy | Maintains | $136 → $128 | +329.82% | Aug 8, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $112 → $105 | Buy | Maintains | $112 → $105 | +252.59% | Aug 6, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +168.64% | Jul 28, 2025 |
Wedbush | Wedbush | Hold Maintains $35 → $34 | Hold | Maintains | $35 → $34 | +14.17% | Jul 14, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +84.69% | Jul 14, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $88 → $65 | Buy | Maintains | $88 → $65 | +118.27% | Jul 10, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates $64 | Strong Buy | Reiterates | $64 | +114.91% | Jun 20, 2025 |
William Blair | William Blair | Buy Initiates $65 | Buy | Initiates | $65 | +118.27% | May 28, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $64 → $65 | Buy | Maintains | $64 → $65 | +118.27% | May 9, 2025 |
JP Morgan | JP Morgan | Buy Maintains $104 → $117 | Buy | Maintains | $104 → $117 | +292.88% | Mar 27, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $140 → $115 | Buy | Maintains | $140 → $115 | +286.17% | Mar 17, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +296.24% | Feb 26, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +219.01% | Feb 18, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 → $136 | Strong Buy | Maintains | $121 → $136 | +356.68% | Feb 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +219.01% | Feb 14, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +296.24% | Jan 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.